Title : Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.

Pub. Date : 2021 Jul

PMID : 34029937






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our findings suggest that corilagin could be a safe and potential antiviral agent against the COVID-19 acting through the blockade of the fusion of SARS-CoV-2 spike-RBD to hACE2 receptors. corilagin surface glycoprotein Severe acute respiratory syndrome coronavirus 2